HOME >> BIOLOGY >> NEWS
Cloudy apple juice four times healthier than clear

Cloudy apple juice is four times healthier than the clear variety, reports Sarah Scoffield in Chemistry & Industry, the magazine of the SCI.

Jan Oszmianski, leading a team at the Agricultural University of Wroclaw, Poland, compared clear and cloudy varieties of apple juice, and found that cloudy juice contains four times the concentration of polyphenols. Polyophenols are also found in dark chocolate, red wine and are widely reported to have anti-caner activity. The research published this month in the SCI's Journal of the Science of Food and Agriculture (DOI: 10.1002/jsfa.2707).

Lucy Ede, Head of Products at the juice company Innocent, said they already use cloudy apple juice in their products. "Cloudy juices taste better and have amazing body, which is important for us," she said. "But the fact that cloudy juices have more health benefits is extra exciting and definitely encourages us to use them."

Clear juice far outsells cloudy juice because of the perception by consumers that is purer. But it is the process of clarification that removes the beneficial compounds locked away in the apple pulp. Retailers also tend to favour clear juice because it has a longer shelf life than cloudy juice.

Also of interest in C&I issue 1 2007:

Super Sausages

Adding orange fibre to the mix allows scientist to make tasty sausages with 60% less fat. The orange fibre not only improves flavour but could also provide health benefits of fruit, which helps fight several conditions such as, colon cancer and heart disease. (JSFA DOI: 10.1002/jsfa)

Extra Special Espresso

The exact conditions required to make the perfect espresso are revealed this week in Chemistry & Industry. Researchers, from the University of Navarro used both electronic 'noses' and human tasters to determine the exact ratio of coffee to water required to avoid the unpleasant tastes of burnt rubber, motor-oil, sulphur and ash associated with o
'"/>

Contact: SCI Press Office
press@soci.org
44-020-759-81548
Society of Chemical Industry
15-Jan-2007


Page: 1 2

Related biology news :

1. An apple peel a day might keep cancer at bay
2. Found -- the apple gene for red
3. UMass Lowell research shows benefits of apple juice on neurotransmitter affecting memory
4. UC Davis researchers reveal apples protective ways
5. HortResearch science reveals the natural potential of apples
6. Apple trees resistant to fire blight and apple scab
7. Age-related memory improvement linked with consumption of apple products
8. An old adage about apples finds scientific backing
9. New study suggests Concord grape juice may provide protection against breast cancer
10. 100 percent juice not associated with overweight in children
11. Pediatrics study shows no link between juice and childrens weight

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cloudy apple juice four times healthier than clear

(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: